The journey following a stem cell transplant can be fraught with complications, none more debilitating than chronic graft-versus-host disease, a condition where donor immune cells relentlessly attack the recipient's body. This review assesses Rezurock (belumosudil) as a critical therapeutic option
For individuals grappling with the relentless and often disfiguring effects of cutaneous lupus erythematosus, the path to effective treatment has been long and fraught with limited options, but a significant development from Biogen offers a new beacon of hope. The U.S. Food and Drug Administration
The intricate global network that delivers life-saving medicines has proven remarkably fragile in recent years, prompting a fundamental rethinking of how and where these complex therapies are produced. In this context, Samsung Biologics' recent acquisition of a major US-based manufacturing facility
For the first time in more than a decade, the therapeutic landscape for newly diagnosed metastatic HER2-positive breast cancer has been fundamentally altered by a landmark U.S. Food and Drug Administration decision. The agency has officially approved a combination therapy featuring Enhertu and
At the forefront of pharmaceutical innovation, Ivan Kairatov is reimagining how essential medicines are made. As a leading expert in biopharma, his work merges the precision of continuous flow chemistry with the intelligence of advanced AI and real-time analytics. In a landscape reshaped by global
What if the complex journey of turning a groundbreaking biologic into a life-saving therapy could be transformed into a streamlined, efficient process? In a world where biopharmaceutical development faces unprecedented challenges, a powerful collaboration between Rentschler Biopharma and Coriolis
